VivoSeq
Other

Prolonged Labor

0

Pipeline Programs

0

Active Trials

0

Companies Involved

Prolonged Labor is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

50/100

Attrition Rate

33/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

3

clinical trials

Terminated1 · 33%
Completed1 · 33%
Unknown status1 · 33%

Trial Activity

Propranolol Rescue of Prolonged Labor
Terminated··Phase 3·NCT04299438·164 enrolled
Hyoscine Butyl Bromide for Management of Prolonged Labor
Unknown status··Phase 3·NCT01854073·500 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)